Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016.

Ferreras E, Matapo B, Chizema-Kawesha E, Chewe O, Mzyece H, Blake A, Moonde L, Zulu G, Poncin M, Sinyange N, Kasese-Chanda N, Phiri C, Malama K, Mukonka V, Cohuet S, Uzzeni F, Ciglenecki I, Danovaro-Holliday MC, Luquero FJ, Pezzoli L.

PLoS One. 2019 Aug 30;14(8):e0219040. doi: 10.1371/journal.pone.0219040. eCollection 2019.

2.

Effectiveness of oral cholera vaccine in preventing cholera among fishermen in Lake Chilwa, Malawi: A case-control study.

Grandesso F, Kasambara W, Page AL, Debes AK, M'bang'ombe M, Palomares A, Lechevalier P, Pezzoli L, Alley I, Salumu L, Msyamboza K, Sack D, Cohuet S, Luquero FJ.

Vaccine. 2019 Jun 19;37(28):3668-3676. doi: 10.1016/j.vaccine.2019.05.044. Epub 2019 May 24.

3.

Estimating cholera incidence with cross-sectional serology.

Azman AS, Lessler J, Luquero FJ, Bhuiyan TR, Khan AI, Chowdhury F, Kabir A, Gurwith M, Weil AA, Harris JB, Calderwood SB, Ryan ET, Qadri F, Leung DT.

Sci Transl Med. 2019 Feb 20;11(480). pii: eaau6242. doi: 10.1126/scitranslmed.aau6242.

4.

Publisher Correction: Genomic insights into the 2016-2017 cholera epidemic in Yemen.

Weill FX, Domman D, Njamkepo E, Almesbahi AA, Naji M, Nasher SS, Rakesh A, Assiri AM, Sharma NC, Kariuki S, Pourshafie MR, Rauzier J, Abubakar A, Carter JY, Wamala JF, Seguin C, Bouchier C, Malliavin T, Bakhshi B, Abulmaali HHN, Kumar D, Njoroge SM, Malik MR, Kiiru J, Luquero FJ, Azman AS, Ramamurthy T, Thomson NR, Quilici ML.

Nature. 2019 Feb;566(7745):E14. doi: 10.1038/s41586-019-0966-0.

PMID:
30755740
5.

Genomic insights into the 2016-2017 cholera epidemic in Yemen.

Weill FX, Domman D, Njamkepo E, Almesbahi AA, Naji M, Nasher SS, Rakesh A, Assiri AM, Sharma NC, Kariuki S, Pourshafie MR, Rauzier J, Abubakar A, Carter JY, Wamala JF, Seguin C, Bouchier C, Malliavin T, Bakhshi B, Abulmaali HHN, Kumar D, Njoroge SM, Malik MR, Kiiru J, Luquero FJ, Azman AS, Ramamurthy T, Thomson NR, Quilici ML.

Nature. 2019 Jan;565(7738):230-233. doi: 10.1038/s41586-018-0818-3. Epub 2019 Jan 2. Erratum in: Nature. 2019 Feb;566(7745):E14.

6.

Oral cholera vaccination in hard-to-reach communities, Lake Chilwa, Malawi.

Grandesso F, Rafael F, Chipeta S, Alley I, Saussier C, Nogareda F, Burns M, Lechevalier P, Page AL, Salumu L, Pezzoli L, Mwesawina M, Cavailler P, Mengel M, Luquero FJ, Cohuet S.

Bull World Health Organ. 2018 Dec 1;96(12):817-825. doi: 10.2471/BLT.17.206417. Epub 2018 Sep 27.

7.

Cholera epidemic in Yemen - Author's reply.

Camacho A, Bouhenia M, Azman AS, Poncin M, Zagaria N, Luquero FJ.

Lancet Glob Health. 2018 Dec;6(12):e1284-e1285. doi: 10.1016/S2214-109X(18)30395-4. Epub 2018 Oct 10. No abstract available.

8.

Progress and Challenges in Using Oral Cholera Vaccines to Control Outbreaks: The Médecins Sans Frontières Experience.

Ciglenecki I, Azman AS, Jamet C, Serafini M, Luquero FJ, Cabrol JC.

J Infect Dis. 2018 Oct 15;218(suppl_3):S165-S166. doi: 10.1093/infdis/jiy487.

9.

Protection of young children with cholera vaccine.

Luquero FJ, Azman AA.

Lancet Infect Dis. 2018 Sep;18(9):947-948. doi: 10.1016/S1473-3099(18)30465-1. No abstract available.

PMID:
30152359
10.

Evaluation of the SD bioline cholera rapid diagnostic test during the 2016 cholera outbreak in Lusaka, Zambia.

Mwaba J, Ferreras E, Chizema-Kawesa E, Mwimbe D, Tafirenyika F, Rauzier J, Blake A, Rakesh A, Poncin M, Stoitsova S, Kwenda G, Azman AS, Chewe O, Serafini M, Lukwesa-Musyani C, Cohuet S, Quilici ML, Luquero FJ, Page AL.

Trop Med Int Health. 2018 Aug;23(8):834-840. doi: 10.1111/tmi.13084. Epub 2018 Jun 29.

11.

Near real-time forecasting for cholera decision making in Haiti after Hurricane Matthew.

Pasetto D, Finger F, Camacho A, Grandesso F, Cohuet S, Lemaitre JC, Azman AS, Luquero FJ, Bertuzzo E, Rinaldo A.

PLoS Comput Biol. 2018 May 16;14(5):e1006127. doi: 10.1371/journal.pcbi.1006127. eCollection 2018 May.

12.

Micro-Hotspots of Risk in Urban Cholera Epidemics.

Azman AS, Luquero FJ, Salje H, Mbaïbardoum NN, Adalbert N, Ali M, Bertuzzo E, Finger F, Toure B, Massing LA, Ramazani R, Saga B, Allan M, Olson D, Leglise J, Porten K, Lessler J.

J Infect Dis. 2018 Aug 24;218(7):1164-1168. doi: 10.1093/infdis/jiy283.

13.

Cholera epidemic in Yemen, 2016-18: an analysis of surveillance data.

Camacho A, Bouhenia M, Alyusfi R, Alkohlani A, Naji MAM, de Radiguès X, Abubakar AM, Almoalmi A, Seguin C, Sagrado MJ, Poncin M, McRae M, Musoke M, Rakesh A, Porten K, Haskew C, Atkins KE, Eggo RM, Azman AS, Broekhuijsen M, Saatcioglu MA, Pezzoli L, Quilici ML, Al-Mesbahy AR, Zagaria N, Luquero FJ.

Lancet Glob Health. 2018 Jun;6(6):e680-e690. doi: 10.1016/S2214-109X(18)30230-4. Epub 2018 May 3.

14.

Cholera Epidemic in South Sudan and Uganda and Need for International Collaboration in Cholera Control.

Abubakar A, Bwire G, Azman AS, Bouhenia M, Deng LL, Wamala JF, Rumunu J, Kagirita A, Rauzier J, Grout L, Martin S, Orach CG, Luquero FJ, Quilici ML.

Emerg Infect Dis. 2018 May;24(5):883-887. doi: 10.3201/eid2405.171651.

15.

The new WHO decision-making framework on vaccine use in acute humanitarian emergencies: MSF experience in Minkaman, South Sudan.

Rull M, Masson S, Peyraud N, Simonelli M, Ventura A, Dorion C, Luquero FJ, Uzzeni F, Cigleneki I.

Confl Health. 2018 Mar 26;12:11. doi: 10.1186/s13031-018-0147-z. eCollection 2018.

16.

Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales.

Lessler J, Moore SM, Luquero FJ, McKay HS, Grais R, Henkens M, Mengel M, Dunoyer J, M'bangombe M, Lee EC, Djingarey MH, Sudre B, Bompangue D, Fraser RSM, Abubakar A, Perea W, Legros D, Azman AS.

Lancet. 2018 May 12;391(10133):1908-1915. doi: 10.1016/S0140-6736(17)33050-7. Epub 2018 Mar 1.

17.

The potential impact of case-area targeted interventions in response to cholera outbreaks: A modeling study.

Finger F, Bertuzzo E, Luquero FJ, Naibei N, Touré B, Allan M, Porten K, Lessler J, Rinaldo A, Azman AS.

PLoS Med. 2018 Feb 27;15(2):e1002509. doi: 10.1371/journal.pmed.1002509. eCollection 2018 Feb.

18.

Single-Dose Cholera Vaccine in Response to an Outbreak in Zambia.

Ferreras E, Chizema-Kawesha E, Blake A, Chewe O, Mwaba J, Zulu G, Poncin M, Rakesh A, Page AL, Stoitsova S, Voute C, Uzzeni F, Robert H, Serafini M, Matapo B, Eiros JM, Quilici ML, Pezzoli L, Azman AS, Cohuet S, Ciglenecki I, Malama K, Luquero FJ.

N Engl J Med. 2018 Feb 8;378(6):577-579. doi: 10.1056/NEJMc1711583. No abstract available.

19.

Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia.

Poncin M, Zulu G, Voute C, Ferreras E, Muleya CM, Malama K, Pezzoli L, Mufunda J, Robert H, Uzzeni F, Luquero FJ, Chizema E, Ciglenecki I.

Bull World Health Organ. 2018 Feb 1;96(2):86-93. doi: 10.2471/BLT.16.189241. Epub 2017 Oct 19.

20.

Dried Blood Spots for Measuring Vibrio cholerae-specific Immune Responses.

Iyer AS, Azman AS, Bouhenia M, Deng LO, Anderson CP, Graves M, Kováč P, Xu P, Ryan ET, Harris JB, Sack DA, Luquero FJ, Leung DT.

PLoS Negl Trop Dis. 2018 Jan 29;12(1):e0006196. doi: 10.1371/journal.pntd.0006196. eCollection 2018 Jan.

21.

High Prevalence of Shigella or Enteroinvasive Escherichia coli Carriage among Residents of an Internally Displaced Persons Camp in South Sudan.

Bliss J, Bouhenia M, Hale P, Couturier BA, Iyer AS, Rumunu J, Martin S, Wamala JF, Abubakar A, Sack DA, Luquero FJ, Couturier MR, Azman AS, Leung DT.

Am J Trop Med Hyg. 2018 Feb;98(2):595-597. doi: 10.4269/ajtmh.17-0339. Epub 2017 Nov 30.

22.

Immunogenicity and Protection From a Single Dose of Internationally Available Killed Oral Cholera Vaccine: A Systematic Review and Metaanalysis.

Lopez AL, Deen J, Azman AS, Luquero FJ, Kanungo S, Dutta S, von Seidlein L, Sack DA.

Clin Infect Dis. 2018 Jun 1;66(12):1960-1971. doi: 10.1093/cid/cix1039.

23.

Genomic history of the seventh pandemic of cholera in Africa.

Weill FX, Domman D, Njamkepo E, Tarr C, Rauzier J, Fawal N, Keddy KH, Salje H, Moore S, Mukhopadhyay AK, Bercion R, Luquero FJ, Ngandjio A, Dosso M, Monakhova E, Garin B, Bouchier C, Pazzani C, Mutreja A, Grunow R, Sidikou F, Bonte L, Breurec S, Damian M, Njanpop-Lafourcade BM, Sapriel G, Page AL, Hamze M, Henkens M, Chowdhury G, Mengel M, Koeck JL, Fournier JM, Dougan G, Grimont PAD, Parkhill J, Holt KE, Piarroux R, Ramamurthy T, Quilici ML, Thomson NR.

Science. 2017 Nov 10;358(6364):785-789. doi: 10.1126/science.aad5901.

PMID:
29123067
24.

Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis.

Bi Q, Ferreras E, Pezzoli L, Legros D, Ivers LC, Date K, Qadri F, Digilio L, Sack DA, Ali M, Lessler J, Luquero FJ, Azman AS; Oral Cholera Vaccine Working Group of The Global Task Force on Cholera Control.

Lancet Infect Dis. 2017 Oct;17(10):1080-1088. doi: 10.1016/S1473-3099(17)30359-6. Epub 2017 Jul 17. Review.

25.

High Hepatitis E Seroprevalence Among Displaced Persons in South Sudan.

Azman AS, Bouhenia M, Iyer AS, Rumunu J, Laku RL, Wamala JF, Rodriguez-Barraquer I, Lessler J, Gignoux E, Luquero FJ, Leung DT, Gurley ES, Ciglenecki I.

Am J Trop Med Hyg. 2017 Jun;96(6):1296-1301. doi: 10.4269/ajtmh.16-0620.

26.

Neighborhood-targeted and case-triggered use of a single dose of oral cholera vaccine in an urban setting: Feasibility and vaccine coverage.

Parker LA, Rumunu J, Jamet C, Kenyi Y, Lino RL, Wamala JF, Mpairwe AM, Muller V, Llosa AE, Uzzeni F, Luquero FJ, Ciglenecki I, Azman AS.

PLoS Negl Trop Dis. 2017 Jun 8;11(6):e0005652. doi: 10.1371/journal.pntd.0005652. eCollection 2017 Jun.

27.

Vaccination against cholera in Juba - Authors' reply.

Ciglenecki I, Azman AS, Rumunu J, Cabrol JC, Luquero FJ.

Lancet Infect Dis. 2017 May;17(5):480-481. doi: 10.1016/S1473-3099(17)30184-6. No abstract available.

PMID:
28447952
28.

El Niño and the shifting geography of cholera in Africa.

Moore SM, Azman AS, Zaitchik BF, Mintz ED, Brunkard J, Legros D, Hill A, McKay H, Luquero FJ, Olson D, Lessler J.

Proc Natl Acad Sci U S A. 2017 Apr 25;114(17):4436-4441. doi: 10.1073/pnas.1617218114. Epub 2017 Apr 10.

29.

Safety of a killed oral cholera vaccine (Shanchol) in pregnant women in Malawi: an observational cohort study.

Ali M, Nelson A, Luquero FJ, Azman AS, Debes AK, M'bang'ombe MM, Seyama L, Kachale E, Zuze K, Malichi D, Zulu F, Msyamboza KP, Kabuluzi S, Sack DA.

Lancet Infect Dis. 2017 May;17(5):538-544. doi: 10.1016/S1473-3099(16)30523-0. Epub 2017 Feb 2.

30.

Adapting to the global shortage of cholera vaccines: targeted single dose cholera vaccine in response to an outbreak in South Sudan.

Parker LA, Rumunu J, Jamet C, Kenyi Y, Lino RL, Wamala JF, Mpairwe AM, Ciglenecki I, Luquero FJ, Azman AS, Cabrol JC.

Lancet Infect Dis. 2017 Apr;17(4):e123-e127. doi: 10.1016/S1473-3099(16)30472-8. Epub 2017 Jan 19. Review.

PMID:
28109819
31.

Cholera Rapid Test with Enrichment Step Has Diagnostic Performance Equivalent to Culture.

Ontweka LN, Deng LO, Rauzier J, Debes AK, Tadesse F, Parker LA, Wamala JF, Bior BK, Lasuba M, But AB, Grandesso F, Jamet C, Cohuet S, Ciglenecki I, Serafini M, Sack DA, Quilici ML, Azman AS, Luquero FJ, Page AL.

PLoS One. 2016 Dec 19;11(12):e0168257. doi: 10.1371/journal.pone.0168257. eCollection 2016.

32.

Ensuring access to oral cholera vaccine to those who need them most.

Luquero FJ, Ballard A, Sack DA.

Vaccine. 2017 Jan 11;35(3):411. doi: 10.1016/j.vaccine.2016.11.074. No abstract available.

PMID:
27916414
33.

Immune Responses to an Oral Cholera Vaccine in Internally Displaced Persons in South Sudan.

Iyer AS, Bouhenia M, Rumunu J, Abubakar A, Gruninger RJ, Pita J, Lino RL, Deng LL, Wamala JF, Ryan ET, Martin S, Legros D, Lessler J, Sack DA, Luquero FJ, Leung DT, Azman AS.

Sci Rep. 2016 Oct 24;6:35742. doi: 10.1038/srep35742.

34.

Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study.

Azman AS, Parker LA, Rumunu J, Tadesse F, Grandesso F, Deng LL, Lino RL, Bior BK, Lasuba M, Page AL, Ontweka L, Llosa AE, Cohuet S, Pezzoli L, Sodjinou DV, Abubakar A, Debes AK, Mpairwe AM, Wamala JF, Jamet C, Lessler J, Sack DA, Quilici ML, Ciglenecki I, Luquero FJ.

Lancet Glob Health. 2016 Nov;4(11):e856-e863. doi: 10.1016/S2214-109X(16)30211-X.

35.

Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial.

Ali M, Debes AK, Luquero FJ, Kim DR, Park JY, Digilio L, Manna B, Kanungo S, Dutta S, Sur D, Bhattacharya SK, Sack DA.

PLoS Med. 2016 Sep 13;13(9):e1002120. doi: 10.1371/journal.pmed.1002120. eCollection 2016 Sep.

36.

Single-Dose Oral Cholera Vaccine in Bangladesh.

Azman AS, Luquero FJ.

N Engl J Med. 2016 Aug 18;375(7):e12. doi: 10.1056/NEJMc1607285. No abstract available.

PMID:
27532851
37.

Population-Level Effect of Cholera Vaccine on Displaced Populations, South Sudan, 2014.

Azman AS, Rumunu J, Abubakar A, West H, Ciglenecki I, Helderman T, Wamala JF, Vázquez Ode L, Perea W, Sack DA, Legros D, Martin S, Lessler J, Luquero FJ.

Emerg Infect Dis. 2016 Jun;22(6):1067-70. doi: 10.3201/eid2206.151592.

38.

High-resolution spatial analysis of cholera patients reported in Artibonite department, Haiti in 2010-2011.

Allan M, Grandesso F, Pierre R, Magloire R, Coldiron M, Martinez-Pino I, Goffeau T, Gitenet R, François G, Olson D, Porten K, Luquero FJ.

Epidemics. 2016 Mar;14:1-10. doi: 10.1016/j.epidem.2015.08.001. Epub 2015 Sep 3.

39.

Correction: The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study.

Azman AS, Luquero FJ, Ciglenecki I, Grais RF, Sack DA, Lessler J.

PLoS Med. 2016 Mar 11;13(3):e1001989. doi: 10.1371/journal.pmed.1001989. eCollection 2016 Mar. No abstract available.

40.

Mortality Rates during Cholera Epidemic, Haiti, 2010-2011.

Luquero FJ, Rondy M, Boncy J, Munger A, Mekaoui H, Rymshaw E, Page AL, Toure B, Degail MA, Nicolas S, Grandesso F, Ginsbourger M, Polonsky J, Alberti KP, Terzian M, Olson D, Porten K, Ciglenecki I.

Emerg Infect Dis. 2016 Mar;22(3):410-6. doi: 10.3201/eid2203.141970.

41.

Safe water, sanitation, hygiene, and a cholera vaccine.

Azman AS, Ivers LC, Legros D, Luquero FJ, Mintz ED.

Lancet. 2016 Jan 2;387(10013):28. doi: 10.1016/S0140-6736(15)01294-5. No abstract available.

PMID:
26766343
42.

Pregnancy Outcomes after a Mass Vaccination Campaign with an Oral Cholera Vaccine in Guinea: A Retrospective Cohort Study.

Grout L, Martinez-Pino I, Ciglenecki I, Keita S, Diallo AA, Traore B, Delamou D, Toure O, Nicholas S, Rusch B, Staderini N, Serafini M, Grais RF, Luquero FJ.

PLoS Negl Trop Dis. 2015 Dec 29;9(12):e0004274. doi: 10.1371/journal.pntd.0004274. eCollection 2015 Dec.

43.

The First Use of the Global Oral Cholera Vaccine Emergency Stockpile: Lessons from South Sudan.

Abubakar A, Azman AS, Rumunu J, Ciglenecki I, Helderman T, West H, Lessler J, Sack DA, Martin S, Perea W, Legros D, Luquero FJ.

PLoS Med. 2015 Nov 17;12(11):e1001901. doi: 10.1371/journal.pmed.1001901. eCollection 2015 Nov. No abstract available.

44.

The scenario approach for countries considering the addition of oral cholera vaccination in cholera preparedness and control plans.

Deen J, von Seidlein L, Luquero FJ, Troeger C, Reyburn R, Lopez AL, Debes A, Sack DA.

Lancet Infect Dis. 2016 Jan;16(1):125-129. doi: 10.1016/S1473-3099(15)00298-4. Epub 2015 Oct 19. Review.

PMID:
26494426
45.

The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study.

Azman AS, Luquero FJ, Ciglenecki I, Grais RF, Sack DA, Lessler J.

PLoS Med. 2015 Aug 25;12(8):e1001867. doi: 10.1371/journal.pmed.1001867. eCollection 2015 Aug. Erratum in: PLoS Med. 2016 Mar;13(3):e1001989.

46.

Long-term efficacy of a hepatitis E vaccine.

Azman AS, Luquero FJ, Ciglenecki I.

N Engl J Med. 2015 Jun 4;372(23):2265. doi: 10.1056/NEJMc1504302. No abstract available.

PMID:
26039605
47.

Geographic distribution and mortality risk factors during the cholera outbreak in a rural region of Haiti, 2010-2011.

Page AL, Ciglenecki I, Jasmin ER, Desvignes L, Grandesso F, Polonsky J, Nicholas S, Alberti KP, Porten K, Luquero FJ.

PLoS Negl Trop Dis. 2015 Mar 26;9(3):e0003605. doi: 10.1371/journal.pntd.0003605. eCollection 2015 Mar.

48.

Outbreaks of cholera in the time of Ebola: pre-emptive action needed.

Azman AS, Legros D, Lessler J, Luquero FJ, Moore SM.

Lancet. 2015 Mar 7;385(9971):851. doi: 10.1016/S0140-6736(15)60178-7. Epub 2015 Feb 20. No abstract available.

PMID:
25703455
49.

Effectiveness of oral cholera vaccine in Haiti.

Luquero FJ, Sack DA.

Lancet Glob Health. 2015 Mar;3(3):e120-1. doi: 10.1016/S2214-109X(15)70015-X. No abstract available.

50.

Post-licensure deployment of oral cholera vaccines: a systematic review.

Martin S, Lopez AL, Bellos A, Deen J, Ali M, Alberti K, Anh DD, Costa A, Grais RF, Legros D, Luquero FJ, Ghai MB, Perea W, Sack DA.

Bull World Health Organ. 2014 Dec 1;92(12):881-93. doi: 10.2471/BLT.14.139949. Epub 2014 Sep 29. Review.

Supplemental Content

Loading ...
Support Center